Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy (semaglutide) can cause a modest increase in resting heart rate in some people — typically around one to four beats per minute above baseline, based on data from the STEP clinical trials. It is not considered clinically significant for most adults, but it is a real pharmacological effect worth understanding before you start treatment. These medicines are prescription-only and require individual clinical assessment; a prescriber considers your full cardiovascular picture, not just your weight.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
GLP-1 receptor agonists like semaglutide act on receptors found not only in the gut but in the nervous system, including the autonomic nerves that regulate heart rate. The current understanding is that activation of GLP-1 receptors in the heart and vasculature produces a mild sympathetic effect, essentially a small increase in the signal telling the heart to beat slightly faster. The result in trials was a mean rise of roughly one to four beats per minute; some individuals see a little more, some nothing at all.
This is different from a cardiac event or an arrhythmia. The heart is still beating rhythmically, it is simply ticking a fraction faster than it did before. Researchers studying the wider cardiovascular picture have noted that this modest rate increase is typically offset by the favourable effects of weight loss on blood pressure, inflammation and metabolic load. The NHS medicines page for semaglutide lists increased heart rate among the possible side effects and advises telling your doctor if you notice it.
If you want to understand how semaglutide interacts with the heart more broadly (including its licensed cardiovascular indication for eligible adults) our page on how semaglutide affects the heart covers that territory in full.
For most people starting Wegovy, a small uptick in resting heart rate sits well within what clinicians consider a normal day-to-day fluctuation. Resting pulse varies by several beats depending on hydration, caffeine, sleep quality and stress, so a two-beat change from a medicine is unlikely to be noticeable in everyday life.
The picture is different if you have a pre-existing heart condition, a history of arrhythmia, or if you are taking medicines whose dosing depends on heart rate (certain beta-blockers, for instance). In those circumstances your prescriber needs to know before treatment starts. That is precisely why clinical assessment is mandatory, not a formality, but a safeguard. Our clinical team reviews each consultation individually, reading your health history rather than running it through a decision tree.
Palpitations (a pounding or racing sensation you can feel) are worth reporting even if your measured pulse is not dramatically elevated. They may reflect anxiety, dehydration from early GI side effects, or, less commonly, a heart-rate response that warrants monitoring. Dehydration is particularly relevant in the first few weeks, when nausea and reduced appetite can mean you are drinking less without realising it. If palpitations are severe, come on suddenly, or are accompanied by chest pain or breathlessness, that is a reason to seek urgent medical attention.
Wegovy is not recommended for people with certain cardiac conditions, and your prescriber will ask about these at consultation. The medicine is also not for those with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome. Pregnancy and breastfeeding are contraindications; if you are planning a pregnancy, our page on Wegovy and pregnancy sets out the current guidance clearly.
For people with well-controlled hypertension or stable cardiovascular disease, Wegovy's wider heart effects are generally considered positive at the population level, the SELECT trial demonstrated a reduction in major cardiovascular events in eligible adults with obesity and established heart disease. A modest heart rate rise does not erase that benefit. The question is whether it matters for your specific cardiac profile, which only a prescriber can assess after reviewing your history.
It is also worth noting that Wegovy's cardiovascular profile was one reason tirzepatide (Mounjaro) and semaglutide have attracted so much research attention. If you are comparing the two medicines on the cardiac side, our detailed cardiac overview for Wegovy and the general Wegovy guide offer a solid starting point before your consultation.
First, measure it properly. Rest quietly for five minutes, then check your pulse for a full minute rather than a 15-second count multiplied by four. Do this at the same time of day, mornings before coffee are ideal. A reading in the 60–100 bpm range is normal for adults at rest; if yours is consistently above 100 (tachycardia), or if you feel something has changed, log it and contact your prescriber.
At nume, aftercare runs seven days a week. A question about heart rate is exactly the kind of thing our team is there for; you do not need to wait until your next monthly review. If you would prefer to talk it through before deciding whether Wegovy is right for you, our FAQs cover many common concerns, and you can always get in touch directly.
The MHRA's Yellow Card scheme also allows patients to report suspected side effects directly to the regulator, worth knowing if you experience something unexpected on any prescription medicine.
On cost: if you are weighing up whether to start treatment privately, our Wegovy cost page sets out what private pricing typically includes beyond the headline figure, so you can compare fairly. Ready to take the next step? Start your free consultation and a GPhC-registered prescriber will review your health history the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.